Publications found:
73,128
Sort by:
Somatostatin Receptor Type 2 - Pipeline Review, H2 2019
US$ 3,500.00
Somatostatin Receptor Type 2 - Pipeline Review, H2 2019 SUMMARY Somatostatin Receptor Type 2 (SRIF1 or SSTR2) pipeline Target constitutes close to 13 molecules. The latest report Somatostatin Recept...
December 2019
71 pages
Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019
US$ 3,500.00
Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019 SUMMARY Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating F...
December 2019
66 pages
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H2 2019
US$ 3,500.00
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H2 2019 SUMMARY Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) pipeline Target con...
December 2019
79 pages
TGF Beta Receptor Type 1 - Pipeline Review, H2 2019
US$ 3,500.00
TGF Beta Receptor Type 1 - Pipeline Review, H2 2019 SUMMARY TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Pro...
December 2019
71 pages
Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019
US$ 3,500.00
Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019'; Tryptophan 2,3 Dioxygenase (Tryptami...
December 2019
40 pages
Tyrosine Protein Kinase CSK - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase CSK - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Tyrosine-protein kinase CSK also know...
December 2019
85 pages
Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) pipeline T...
December 2019
103 pages
Tyrosine Protein Kinase ITKTSK - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase ITKTSK - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein K...
December 2019
66 pages
Muscle Spasticity - Pipeline Review, H2 2019
US$ 2,000.00
Muscle Spasticity - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Spasticity - Pipeline Review, H2 2019, provides an ove...
December 2019
110 pages
Postoperative Ileus - Pipeline Review, H2 2019
US$ 2,000.00
Postoperative Ileus - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Postoperative Ileus - Pipeline Review, H2 2019, provides an...
December 2019
40 pages
Country Chartbook - Healthcare Indicators: The Euro Area
US$ 100.00
Country Chartbook - Healthcare Indicators: The Euro Area SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encour...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: European Union
US$ 100.00
Country Chartbook - Healthcare Indicators: European Union SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encou...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: Europe
US$ 100.00
Country Chartbook - Healthcare Indicators: Europe SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encourage eco...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: The G20
US$ 100.00
Country Chartbook - Healthcare Indicators: The G20 SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encourage ec...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: The G8
US$ 100.00
Country Chartbook - Healthcare Indicators: The G8 SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encourage eco...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: NAFTA
US$ 100.00
Country Chartbook - Healthcare Indicators: NAFTA SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encourage econ...
December 2019
15 pages
Country Chartbook - Healthcare Indicators: The OECD
US$ 100.00
Country Chartbook - Healthcare Indicators: The OECD SUMMARY With global populations rapidly increasing, the provision of healthcare has never been more important in improving workforces to encourage e...
December 2019
15 pages
Livestock Grow Lights Market Size, Share & Trends Analysis Report By Type (Fluorescent, Incandescent, LED), By Livestock, By Installation Type, By Light Color Type, By Region, And Segment Forecasts, 2019 - 2025
US$ 4,950.00
This report can be delivered to the clients within 12-14 business days The global livestock grow lights market size is estimated to reach USD 10.4 billion by 2025, growing at a CAGR of 6.8% from 201...
December 2019
110 pages
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2019
US$ 2,500.00
... Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
2792 pages
Neuropathic Pain - Pipeline Review, H2 2019
US$ 2,500.00
... . The Neuropathic Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuropathic Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
838 pages
Peptic Ulcers - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Peptic Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peptic Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
66 pages
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019
US$ 2,000.00
... Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
615 pages
Female Sexual Dysfunction - Pipeline Review, H2 2019
US$ 2,000.00
... . The Female Sexual Dysfunction (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Sexual Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
83 pages
Premenstrual Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Premenstrual Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premenstrual Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
37 pages
Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2019
US$ 2,500.00
... releases. The Multiple Myeloma (Kahler Disease) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Multiple Myeloma (Kahler Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
2062 pages
Myelodysplastic Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myelodysplastic Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Myelodysplastic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
1542 pages
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2019
US$ 2,500.00
... Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
1463 pages
Enterocolitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Enterocolitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Enterocolitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
54 pages
Toxoplasmosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Toxoplasmosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Toxoplasmosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
45 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Cervical Intraepithelial Neoplasia (CIN) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Cervical Intraepithelial Neoplasia (CIN) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
133 pages
Canavan Disease - Pipeline Review, H2 2019
US$ 2,000.00
... . The Canavan Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Canavan Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
36 pages
